| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | EAGLE PHARMACEUTICALS INC COM | 4,780,188 | 353,877,000 | 83.76% | ||
| 2 | Agile Therapeutics, Inc. | 4,668,663 | 31,467,000 | 7.45% | ||
| 3 | IMMUNE DESIGN CORP COM | 1,962,720 | 23,945,000 | 5.67% | ||
| 4 | ANTHERA PHARMACEUTICALS I | 1,900,000 | 11,571,000 | 2.74% | ||
| 5 | Zosano Pharma Corp | 229,759 | 910,000 | 0.22% | ||
| 6 | MAST THERAPEUTICS | 1,275,925 | 740,000 | 0.18% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000932440-15-000282, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
